102
Views
5
CrossRef citations to date
0
Altmetric
Original Research

The Effect of Cytoreductive Partial Nephrectomy in Elderly Patients with Metastatic Renal Cell Carcinoma

, , , & ORCID Icon
Pages 431-439 | Published online: 20 Mar 2020

References

  • Kanesvaran R, Le SO, Motzer R, et al. Elderly patients with metastatic renal cell carcinoma: position paper from the International society of geriatric oncology. Lancet Oncol. 2018;19(6):e317–317e326. doi:10.1016/S1470-2045(18)30125-629893263
  • Méjean A, Ravaud A, Thezenas S, et al. Sunitinib alone or after nephrectomy in metastatic renal-cell carcinoma. N Engl J Med. 2018;379(5):417–427. doi:10.1056/NEJMoa180367529860937
  • Arora S, Sood A, Dalela D, et al. Cytoreductive nephrectomy: assessing the generalizability of the CARMENA trial to real-world national cancer data base cases. Eur Urol. 2019;75(2):352–353. doi:10.1016/j.eururo.2018.10.05430420256
  • Motzer RJ, Russo P. Cytoreductive nephrectomy - patient selection is key. N Engl J Med. 2018;379(5):481–482. doi:10.1056/NEJMe180633129860908
  • Bhanvadia S, Pal SK. Cytoreductive nephrectomy: questions remain after CARMENA. Nat Rev Urol. 2018;15(9):530–532. doi:10.1038/s41585-018-0064-330054576
  • Massari F, Di NV, Gatto L, et al. Should CARMENA really change our attitude towards cytoreductive nephrectomy in metastatic renal cell carcinoma? A systematic review and meta-analysis evaluating cytoreductive nephrectomy in the era of targeted therapy. Target Oncol. 2018;13(6):705–714. doi:10.1007/s11523-018-0601-230324488
  • Mazzone E, Nazzani S, Preisser F, et al. Partial nephrectomy seems to confer a survival benefit relative to radical nephrectomy in metastatic renal cell carcinoma. Cancer Epidemiol. 2018;56:118–125. doi:10.1016/j.canep.2018.08.00630173050
  • Peyton CC, Rothberg MB, Jiang V, Heavner MG, Hemal AK. Comparative analysis of renal functional outcomes and overall survival of elderly vs nonelderly patients undergoing radical nephrectomy. J Endourol. 2017;31(2):198–203. doi:10.1089/end.2016.052527881019
  • Hellenthal NJ, Mansour AM, Hayn MH, Schwaab T. Is there a role for partial nephrectomy in patients with metastatic renal cell carcinoma. Urol Oncol. 2013;31(1):36–41. doi:10.1016/j.urolonc.2010.08.02621396834
  • Mir MC, Pavan N, Capitanio U, et al. Partial versus radical nephrectomy in very elderly patients: a propensity score analysis of surgical, functional and oncologic outcomes (RESURGE project). World J Urol. 2019.
  • Kates M, Badalato G, Pitman M, McKiernan J. Persistent overuse of radical nephrectomy in the elderly. Urology. 2011;78(3):555–559. doi:10.1016/j.urology.2011.02.06621777962
  • Zanardi E, Grassi P, Cavo A, et al. Treatment of elderly patients with metastatic renal cell carcinoma. Expert Rev Anticancer Ther. 2016;16(3):323–334. doi:10.1586/14737140.2016.113161326654225
  • Huang F, DU C S, Ning M, Luo B, An Y. Propensity score matching in SPSS. Nan Fang Yi Ke Da Xue Xue Bao. 2015;35(11):1597–1601.26607082
  • Iasonos A, Schrag D, Raj GV, Panageas KS. How to build and interpret a nomogram for cancer prognosis. J Clin Oncol. 2008;26(8):1364–1370. doi:10.1200/JCO.2007.12.979118323559
  • Ristau BT, Handorf EA, Cahn DB, Kutikov A, Uzzo RG, Smaldone MC. Partial nephrectomy is not associated with an overall survival advantage over radical nephrectomy in elderly patients with stage Ib-II renal masses: an analysis of the national cancer data base. Cancer. 2018;124(19):3839–3848. doi:10.1002/cncr.3158230207380
  • An JY, Ball MW, Gorin MA, et al. Partial vs radical nephrectomy for T1-T2 renal masses in the elderly: comparison of complications, renal function, and oncologic outcomes. Urology. 2017;100:151–157. doi:10.1016/j.urology.2016.10.04727889493
  • Capitanio U, Terrone C, Antonelli A, et al. Nephron-sparing techniques independently decrease the risk of cardiovascular events relative to radical nephrectomy in patients with a T1a-T1b renal mass and normal preoperative renal function. Eur Urol. 2015;67(4):683–689. doi:10.1016/j.eururo.2014.09.02725282367
  • Lenis AT, Salmasi AH, Donin NM, et al. Trends in usage of cytoreductive partial nephrectomy and effect on overall survival in patients with metastatic renal cell carcinoma. Urol Oncol. 2018;36(2):78.e21–78.e28. doi:10.1016/j.urolonc.2017.09.030
  • Mathieu R, Pignot G, Ingles A, et al. Nephrectomy improves overall survival in patients with metastatic renal cell carcinoma in cases of favorable MSKCC or ECOG prognostic features. Urol Oncol. 2015;33(8):339.e9–15. doi:10.1016/j.urolonc.2015.05.014
  • Patel MI, Beattie K, Bang A, Gurney H, Smith DP. Cytoreductive nephrectomy for metastatic renal cell carcinoma: inequities in access exist despite improved survival. Cancer Med. 2017;6(10):2188–2193. doi:10.1002/cam4.2017.6.issue-1028834281
  • Uprety D, Bista A, Smith AL, Vallatharasu Y, Marinier DE. Cytoreductive nephrectomy in elderly patients with metastatic renal cell carcinoma in the targeted therapy era. Anticancer Res. 2018;38(5):3013–3018. doi:10.21873/anticanres.1255529715133
  • Roos FC, Brenner W, Jäger W, et al. Perioperative morbidity and renal function in young and elderly patients undergoing elective nephron-sparing surgery or radical nephrectomy for renal tumours larger than 4 cm. BJU Int. 2011;107(4):554–561. doi:10.1111/j.1464-410X.2010.09516.x20707798
  • Hillyer SP, Autorino R, Spana G, et al. Perioperative outcomes of robotic-assisted partial nephrectomy in elderly patients: a matched-cohort study. Urology. 2012;79(5):1063–1067. doi:10.1016/j.urology.2011.12.05622546384
  • Sandberg JM, Krane LS, Hemal AK. A nonrandomized prospective comparison of robotic-assisted partial nephrectomy in the elderly to a younger cohort: an analysis of 339 patients with intermediate-term follow-up. Urology. 2014;84(4):838–843. doi:10.1016/j.urology.2014.07.00425260445